SCHEMBL24809677

SCHEMBL24809677

COc1nc(C(C)(C)C)cn1C(=O)NCC#CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24809433 0.84 RXFP1 (0.30)
SCHEMBL24811114 0.83 PDCD1LG2 (0.30)
SCHEMBL24809346 0.83 ASAH1 (0.38)
SCHEMBL24809410 0.81 HPGD (0.38)
SCHEMBL24809412 0.79 BRD4 (0.36)
SCHEMBL24810815 0.77 PDE10A (0.38)
SCHEMBL24809680 0.76
SCHEMBL24809756 0.74 ASAH1 (0.36)
SCHEMBL24809406 0.73 NAMPT (0.36)
SCHEMBL24809400 0.73 ASAH1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411388-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL R&D INVEST S A (PT) 2022-12-29 US disclosed
EP-4031531-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed